Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

Characterization of Epigenetic Gene Silencing in a Subtype of Acute Leukemia Patients with a Poor Prognosis

FY 2009-10

Summary
Acute leukemia is a rapidly progressing disease. It is generally divided into myeloid and lymphoid lineages. Each lineage of acute leukemia is defined by distinct treatment and prognosis. However, a subtype of acute leukemia cases, identified as Cluster 4, exhibit features of both lineages. Thus, Cluster 4 cases are biologically unique and hard to diagnose. Patients belonging to Cluster 4 have a very poor prognosis due to the ineffectiveness of current treatment methods and thus, they are in need of a new therapeutic approach. The repression of tumor suppressor genes characterizes Cluster 4 cases. The repression of these genes is an important determinant of cancer development. I will investigate whether the suppression of these tumor suppressor genes in Cluster 4 cases involves the two major mechanisms of epigenetic silencing: (i) Polycomb Group (PcG) protein recruitment (ii) DNA promoter methylation. My plan of study has three aims: (1) Identification of Cluster 4 Patient Samples: I plan to screen a collection of leukemia patient samples and select the samples that exhibit gene expression levels characteristic of Cluster 4 cases. (2) Identification of PcG Protein Promoter Binding Sites: As the recruitment of PcG proteins to a region of DNA can result gene silencing, I will determine if PcG proteins are recruited to bind DNA. The finding that PcG proteins are atypically recruited to DNA binding sites will lead the way to identifying a protein that acts to nucleate the recruitment of the PcG. (3) Analysis of Promoter Methylation: I aim to examine gene promoter methylation of genes of interest, by isolating DNA from normal blood and bone marrow samples and Cluster 4 samples, and performing an assay that can detect the methylation status of DNA. By comparing the resulting methylation patterns of normal cells with leukemia patient cells, I will be able to determine if promoter methylation contributes to genetic silencing. In summary, by correlating the contributio
Program
Master's Award: Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
201064
Name
Sepiashvili Lusia
Region
Ontario
Country
Canada
Orgtype
Research Institution; Institution Paid
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Canada Graduate Scholarships Master's Awards A
Projecttitle
Characterization of Epigenetic Gene Silencing in a Subtype of Acute Leukemia Patients with a Poor Prognosis
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Chromatin Immunoprecipitation; Cpg Island Microarray; Dna Methylation; Epigenetics; Leukemia; Polycomb Group Proteins; Reverse Transcription Polymerase Chain Reaction
Abstract
Acute leukemia is a rapidly progressing disease. It is generally divided into myeloid and lymphoid lineages. Each lineage of acute leukemia is defined by distinct treatment and prognosis. However, a subtype of acute leukemia cases, identified as Cluster 4, exhibit features of both lineages. Thus, Cluster 4 cases are biologically unique and hard to diagnose. Patients belonging to Cluster 4 have a very poor prognosis due to the ineffectiveness of current treatment methods and thus, they are in need of a new therapeutic approach. The repression of tumor suppressor genes characterizes Cluster 4 cases. The repression of these genes is an important determinant of cancer development. I will investigate whether the suppression of these tumor suppressor genes in Cluster 4 cases involves the two major mechanisms of epigenetic silencing: (i) Polycomb Group (PcG) protein recruitment (ii) DNA promoter methylation. My plan of study has three aims: (1) Identification of Cluster 4 Patient Samples: I plan to screen a collection of leukemia patient samples and select the samples that exhibit gene expression levels characteristic of Cluster 4 cases. (2) Identification of PcG Protein Promoter Binding Sites: As the recruitment of PcG proteins to a region of DNA can result gene silencing, I will determine if PcG proteins are recruited to bind DNA. The finding that PcG proteins are atypically recruited to DNA binding sites will lead the way to identifying a protein that acts to nucleate the recruitment of the PcG. (3) Analysis of Promoter Methylation: I aim to examine gene promoter methylation of genes of interest, by isolating DNA from normal blood and bone marrow samples and Cluster 4 samples, and performing an assay that can detect the methylation status of DNA. By comparing the resulting methylation patterns of normal cells with leukemia patient cells, I will be able to determine if promoter methylation contributes to genetic silencing. In summary, by correlating the contributio
Competitiondate
201002
Approvedterm2
1 yr 0 mth
Pinamesdelim
Sepiashvili, Lusia
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~